Pyrophyte Acquisition (PHYT) - 2022 Q2 - Quarterly Report

PART I – FINANCIAL INFORMATION Item 1. Condensed Financial Statements The unaudited statements show the company's pre-business combination status, with a net income of $4.0 million for H1 2022 driven by non-cash gains Condensed Balance Sheets Condensed Balance Sheet Highlights (Unaudited) | Financial Item | June 30, 2022 | December 31, 2021 | | :--- | :--- | :--- | | Assets | | | | Cash | $395,164 | $966,695 | | Investments and cash held in Trust Account | $206,666,699 | $206,299,296 | | Total Assets | $207,612,968 | $207,945,686 | | Liabilities & Equity | | | | Total Liabilities | $15,719,071 | $20,080,666 | | Derivative warrant liabilities | $6,065,625 | $11,506,893 | | Class A ordinary shares subject to possible redemption | $206,566,699 | $206,281,250 | | Total shareholders' deficit | $(14,672,802) | $(18,416,230) | Condensed Statements of Operations Condensed Statements of Operations Highlights (Unaudited) | Financial Item | Three Months Ended June 30, 2022 | Six Months Ended June 30, 2022 | | :--- | :--- | :--- | | Loss from operations | $(446,213) | $(1,779,811) | | Change in fair value of derivative warrant liabilities | $3,064,897 | $5,441,268 | | Gain on investments held in Trust Account | $291,044 | $367,403 | | Net income (loss) | $2,909,745 | $4,028,877 | Condensed Statements of Cash Flows - For the six months ended June 30, 2022, net cash used in operating activities was $571,531, resulting from a net income of $4.0 million adjusted primarily for a non-cash gain of $5.4 million from the change in fair value of derivative warrant liabilities and a $0.4 million gain on investments21 Notes to Unaudited Condensed Financial Statements - The Company is a blank check company that consummated its Initial Public Offering (IPO) on October 29, 2021, raising gross proceeds of $201.25 million2527 - The Company has until April 29, 2023, to complete a Business Combination, or it will be required to cease operations and redeem all public shares37 - Management identified and restated errors in its Q1 2022 financial statements related to overstated accrued expenses and understated deferred legal fees46 - Management determined there is substantial doubt about the Company's ability to continue as a going concern due to the impending business combination deadline4445 - The Company's outstanding warrants are classified as derivative liabilities, resulting in a non-cash gain of $5,441,268 for the six months ended June 30, 2022, due to a decrease in their fair value69115 Management's Discussion and Analysis of Financial Condition and Results of Operations Management discusses the company's status as a blank check company seeking an energy transition business combination, its financial results, and going concern doubts - The company is a blank check company seeking to acquire a business in the energy transition sector, focusing on technologies that support decarbonization122 - As of the IPO closing, $206,281,250 ($10.25 per unit) of net proceeds were placed in a trust account, and the company has until April 29, 2023, to complete an initial business combination125127 - For the six months ended June 30, 2022, the company had a net income of $4,028,877, driven by a $5,441,268 gain in fair value of derivative warrant liabilities that offset operating costs129 - Management has determined that liquidity conditions raise substantial doubt about the Company's ability to continue as a going concern for the next year139 Quantitative and Qualitative Disclosures About Market Risk The company is exempt from this disclosure requirement as it qualifies as a smaller reporting company - As a smaller reporting company, the registrant is not required to provide quantitative and qualitative disclosures about market risk158 Controls and Procedures Management concluded that disclosure controls were ineffective due to a material weakness in financial reporting related to accruals and complex financial instruments - Management concluded that as of June 30, 2022, the company's disclosure controls and procedures were not effective160 - A material weakness in internal control over financial reporting was identified related to the process of recording accruals and the accounting of complex financial instruments161 PART II–OTHER INFORMATION Legal Proceedings The company reports no current legal proceedings - The company has no legal proceedings to report166 Risk Factors Key risks include a material weakness in internal controls, potential adverse effects from proposed SEC rules for SPACs, and macroeconomic uncertainties - A material weakness in internal control over financial reporting has been identified, which could adversely affect investor confidence and timely financial reporting168169 - Proposed SEC rules related to SPACs could materially and adversely affect the company's ability to complete its initial business combination and may increase associated costs173 - The search for a business combination may be materially and adversely affected by global events, including the COVID-19 outbreak and the invasion of Ukraine by Russia174177 Unregistered Sales of Equity Securities and Use of Proceeds The company details the use of proceeds from its IPO and private placement, with $206.3 million placed in its trust account - On October 29, 2021, the company consummated its IPO of 20,125,000 units, generating gross proceeds of $201,250,000182 - Simultaneously with the IPO, the company sold 10,156,250 private placement warrants to its sponsor, generating proceeds of $10,156,250183 - A total of $206,281,250 from the IPO and private placement was deposited into the Trust Account185 Defaults Upon Senior Securities The company reports no defaults upon senior securities - None186 Mine Safety Disclosures This disclosure requirement is not applicable to the company - Not applicable187 Other Information The company reports no other information for disclosure - None188 Exhibits This section lists filed exhibits, including officer certifications required by the Sarbanes-Oxley Act and XBRL data files - The report includes CEO and CFO certifications as required by Sections 302 and 906 of the Sarbanes-Oxley Act of 2002189